1. Up Front

   Up Front 27 October 2017 Pages: 2317 - 2318

2. Improving the clinical value and utility of CGM systems: issues and recommendations

   • John R. Petrie
   • Anne L. Peters
   • Lutz Heinemann

   Position statement 25 October 2017 Pages: 2319 - 2328

   

3. Exercise training response heterogeneity: physiological and molecular insights

   • Lauren M. Sparks

   Review 14 October 2017 Pages: 2329 - 2336

   

4. Osteomyelitis of the foot: non-surgical management, SPECT/CT scanning and minimising the duration of antibiotic use

   • William J. Jeffcoate

   Commentary 21 September 2017 Pages: 2337 - 2340

   

5. Non-alcoholic fatty liver disease and impaired proinsulin conversion as newly identified predictors of the long-term non-response to a lifestyle intervention for diabetes prevention: results from the TULIP study

   • Vera Schmid
   • Robert Wagner
   • Andreas Fritsche

   Article 24 August 2017 Pages: 2341 - 2351

   

6. Increased plasma N-glycome complexity is associated with higher risk of type 2 diabetes

   • Toma Keser
   • Ivan Gornik
   • Olga Gornik

   Article 13 September 2017 Pages: 2352 - 2360

   

7. Spatial distribution of early red lesions is a risk factor for development of vision-threatening diabetic retinopathy

   • Giovanni Ometto
   • Phil Assheton
   • Toke Bek

   Article Open access 07 September 2017 Pages: 2361 - 2367

   

8. Gestational retinal microvasculature and the risk of 5 year postpartum abnormal glucose metabolism

   • Ling-Jun Li
   • Kok Hian Tan
   • Tien Yin Wong

   Article 22 September 2017 Pages: 2368 - 2376

   

9. Termination of pregnancy and sterilisation in women with childhood-onset type 1 diabetes

   • Lena Sjöberg
   • Risto Kaaja
   • Janne Pitkäniemi

   Article Open access 11 September 2017 Pages: 2377 - 2383

   

10. Transethnic insight into the genetics of glycaemic traits: fine-mapping results from the Population Architecture using Genomics and Epidemiology (PAGE) consortium

    • Stephanie A. Bien
    • James S. Pankow
    • Charles Kooperberg

    Article Open access 13 September 2017 Pages: 2384 - 2398

    

11. Gcg ^CreERT2 knockin mice as a tool for genetic manipulation in pancreatic alpha cells

    • Chiyo Shiota
    • Krishna Prasadan
    • George K. Gittes

    Article 07 September 2017 Pages: 2399 - 2408

    

12. Differential modulation of IL-12 family cytokines in autoimmune islet graft failure in mice

    • Feng-Cheng Chou
    • Heng-Yi Chen
    • Huey-Kang Sytwu

    Article 19 September 2017 Pages: 2409 - 2417

    

13. Multipeptide-coupled nanoparticles induce tolerance in ‘humanised’ HLA-transgenic mice and inhibit diabetogenic CD8⁺ T cell responses in type 1 diabetes

    • Xinyu Xu
    • Lingling Bian
    • Tao Yang

    Article 08 September 2017 Pages: 2418 - 2431

    

14. Glucose effectiveness, but not insulin sensitivity, is improved after short-term interval training in individuals with type 2 diabetes mellitus: a controlled, randomised, crossover trial

    • Kristian Karstoft
    • Margaret A. Clark
    • Thomas P. J. Solomon

    Article 25 August 2017 Pages: 2432 - 2442

    

15. KLF10 transcription factor regulates hepatic glucose metabolism in mice

    • Xiaoying Yang
    • Qi Chen
    • Yongsheng Chang

    Article 23 August 2017 Pages: 2443 - 2452

    

16. The MST3/STK24 kinase mediates impaired fasting blood glucose after a high-fat diet

    • Cristina Iglesias
    • Ebel Floridia
    • Juan Zalvide

    Article 27 September 2017 Pages: 2453 - 2462

    

17. Liver-specific reconstitution of CEACAM1 reverses the metabolic abnormalities caused by its global deletion in male mice

    • Lucia Russo
    • Harrison T. Muturi
    • Sonia M. Najjar

    Article 14 September 2017 Pages: 2463 - 2474

    

18. Chylomicrons stimulate incretin secretion in mouse and human cells

    • Arianna Psichas
    • Pierre F. Larraufie
    • Frank Reimann

    Article Open access 02 September 2017 Pages: 2475 - 2485

    

19. Application of white blood cell SPECT/CT to predict remission after a 6 or 12 week course of antibiotic treatment for diabetic foot osteomyelitis

    • Julien Vouillarmet
    • Myriam Moret
    • Julien Dubreuil

    Article 02 September 2017 Pages: 2486 - 2494

    

20. Patterns of cutaneous nerve fibre loss and regeneration in type 2 diabetes with painful and painless polyneuropathy

    • Gidon J. Bönhof
    • Alexander Strom
    • Dan Ziegler

    Article 15 September 2017 Pages: 2495 - 2503

    

21. Assessment of glucose regulation in pregnancy after gastric bypass surgery

    • Christian S. Göbl
    • Latife Bozkurt
    • Alexandra Kautzky-Willer

    Article Open access 16 September 2017 Pages: 2504 - 2513

    

22. Circulating adipokines are associated with pre-eclampsia in women with type 1 diabetes

    • Clare B. Kelly
    • Michelle B. Hookham
    • Timothy J. Lyons

    Article 05 September 2017 Pages: 2514 - 2524

23. South Asian men have lower expression of IFN signalling genes in white adipose tissue and skeletal muscle compared with white men

    • Andrea D. van Dam
    • Mark J. W. Hanssen
    • Mariëtte R. Boon

    Research Letter 08 September 2017 Pages: 2525 - 2528

    

24. Lower corneal nerve fibre length identifies diabetic neuropathy in older adults with diabetes: results from the Canadian Study of Longevity in Type 1 Diabetes

    • Daniel Scarr
    • Leif E. Lovblom
    • Bruce A. Perkins

    Research Letter 03 October 2017 Pages: 2529 - 2531

25. Europe has to step up its efforts to produce innovative and safe diabetes technology

    • Miriam Cnop
    • Tomasz Klupa
    • Mischa van Eimeren

    Letter 24 September 2017 Pages: 2532 - 2533

26. Bladder cancer in the EMPA-REG OUTCOME trial

    • Sven Kohler
    • Jisoo Lee
    • Bernard Zinman

    Letter Open access 14 September 2017 Pages: 2534 - 2535

27. SGLT2 inhibitors and cancer: why further evidence is required

    • Altamash M. Y. Shaikh

    Letter 13 September 2017 Pages: 2536 - 2537

28. Cancer risk in the EMPA-REG OUTCOME trial. Reply to Shaikh AMY [letter] and Kohler S, Lee J, George JT et al [letter]

    • Huilin Tang
    • Jiali Han
    • Yiqing Song

    Letter 17 September 2017 Pages: 2538 - 2539

29. Erratum to: Understanding and preventing type 1 diabetes through the unique working model of TrialNet

    • Manuela Battaglia
    • Mark S. Anderson
    • Mark Peakman

    Erratum 26 September 2017 Pages: 2540 - 2540

30. Erratum to: Innovative technology shows impact of glycaemic control on peripheral retinal vessels in adolescents with type 1 diabetes

    • Valli Velayutham
    • Paul Z. Benitez-Aguirre
    • Kim C. Donaghue

    Correction 01 October 2017 Pages: 2541 - 2541

31. Correction to: Transethnic insight into the genetics of glycaemic traits: fine-mapping results from the Population Architecture using Genomics and Epidemiology (PAGE) consortium

    • Stephanie A. Bien
    • James S. Pankow
    • Charles Kooperberg

    Correction 16 October 2017 Pages: 2542 - 2543

32. Correction to: Islet-intrinsic effects of CFTR mutation

    • Fiona N. Manderson Koivula
    • Neville H. McClenaghan
    • Catriona Kelly

    Correction 23 October 2017 Pages: 2544 - 2544